TRIKAFTA tablets. FDA-Approved. To treat cystic fibrosis (CF)

TRIKAFTA is a prescription medicine. TRIKAFTA is used to treat cystic fibrosis (CF).
INDICATIONS AND USAGE
TRIKAFTA is a combination of ivacaftor, a CFTR potentiator, tezacaftor, and elexacaftor indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene. If the patient’s genotype is unknown, an FDA-cleared CF mutation test should be used to confirm the presence of at least one F508del mutation.
DOSAGE FORMS & STRENGTHS

• Tablets: fixed dose combination containing elexacaftor 100 mg, tezacaftor 50 mg and ivacaftor 75 mg.
  Co-packaged with: • Tablets: ivacaftor 150 mg.

Manufactured By: Vertex Pharmaceuticals Incorporated
Prescribing Information URL: Click Here

South Delhi Pharma facilitate the supply of “TRIKAFTA FDA Approved” medication. Supplied under Named Patient Program to all locations in India and other part of countries. Anti-Cancer drugs is available upon request after fulfilling the legal requirement (if applicable). To get best price share your mobile number and email ID.